Literature DB >> 20881941

Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease.

Sriharsha Damera1, Kalani L Raphael, Bradley C Baird, Alfred K Cheung, Tom Greene, Srinivasan Beddhu.   

Abstract

High serum alkaline phosphatase concentrations are associated with elevated serum C-reactive protein (CRP) levels in the general population. To examine whether this association is independent of serum vitamin D levels or modified in chronic kidney disease (CKD), we determined if such associations exist using data from the National Health and Nutrition Examination Survey III of 14,420 adult participants in which 5.7% had CKD (defined as estimated glomerular filtration rate < 60 ml/min per 1.73 m²). For each doubling of serum alkaline phosphatase, the odds of elevated serum CRP (over 3 mg/l) were increased 2.73-fold in the non-chronic and 2.50-fold in the CKD sub-populations, respectively. Regression coefficients of each doubling of serum alkaline phosphatase with elevated CRP were not significantly different in between the sub-populations. Additional adjustment for the serum 25-hydroxy (OH) vitamin D level did not substantively change the results. Thus, associations of serum alkaline phosphatase with elevated CRP are independent of serum 25-OH vitamin D in the chronic and non-CKD populations. Hence, serum alkaline phosphatase might be a marker of the inflammatory milieu.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881941      PMCID: PMC5260661          DOI: 10.1038/ki.2010.356

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  23 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death.

Authors:  Margaret J Blayney; Ronald L Pisoni; Jennifer L Bragg-Gresham; Juergen Bommer; Luis Piera; Akira Saito; Takashi Akiba; Marcia L Keen; Eric W Young; Friedrich K Port
Journal:  Kidney Int       Date:  2008-06-11       Impact factor: 10.612

3.  Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.

Authors:  P Magnusson; C A Sharp; M Magnusson; J Risteli; M W Davie; L Larsson
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

4.  Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.

Authors:  S Fletcher; R G Jones; H C Rayner; P Harnden; L D Hordon; J E Aaron; B Oldroyd; A M Brownjohn; J H Turney; M A Smith
Journal:  Nephron       Date:  1997       Impact factor: 2.847

5.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

6.  Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease.

Authors:  Vandana Menon; Xuelei Wang; Tom Greene; Gerald J Beck; John W Kusek; Santica M Marcovina; Andrew S Levey; Mark J Sarnak
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

7.  Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

Authors:  Deborah L Regidor; Csaba P Kovesdy; Rajnish Mehrotra; Mehdi Rambod; Jennie Jing; Charles J McAllister; David Van Wyck; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 10.121

8.  Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.

Authors:  K A Lomashvili; P Garg; S Narisawa; J L Millan; W C O'Neill
Journal:  Kidney Int       Date:  2008-02-20       Impact factor: 10.612

9.  Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.

Authors:  Mhairi K Sigrist; Maarten W Taal; Peter Bungay; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-10       Impact factor: 8.237

Review 10.  Fatty liver: a novel component of the metabolic syndrome.

Authors:  Anna Kotronen; Hannele Yki-Järvinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-09       Impact factor: 8.311

View more
  29 in total

Review 1.  Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.

Authors:  Mathias Haarhaus; Vincent Brandenburg; Kamyar Kalantar-Zadeh; Peter Stenvinkel; Per Magnusson
Journal:  Nat Rev Nephrol       Date:  2017-05-15       Impact factor: 28.314

2.  Prognostic significance of pre-end-stage renal disease serum alkaline phosphatase for post-end-stage renal disease mortality in late-stage chronic kidney disease patients transitioning to dialysis.

Authors:  Keiichi Sumida; Miklos Z Molnar; Praveen K Potukuchi; Fridtjof Thomas; Jun Ling Lu; Yoshitsugu Obi; Connie M Rhee; Elani Streja; Kunihiro Yamagata; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2018-02-01       Impact factor: 5.992

3.  Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.

Authors:  Connie M Rhee; Miklos Z Molnar; Wei Ling Lau; Vanessa Ravel; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

4.  Liver Function Enzymes are Potential Predictive Markers for Kidney Allograft Dysfunction.

Authors:  Alakesh Bera; Eric Russ; Rahul M Jindal; Maura A Watson; Robert Nee; Ofer Eidelman; John Karaian; Harvey B Pollard; Meera Srivastava
Journal:  Adv J Urol Nephrol       Date:  2020-03-03

5.  Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients.

Authors:  Yan Wang; Feng Xiong; Jian Yang; Tingting Xia; Zhenyu Jia; Jiaqing Shen; Chunfang Xu; Jun Feng; Yongda Lu
Journal:  J Gastrointest Oncol       Date:  2021-08

6.  Prognostic significance of albumin to alkaline phosphatase ratio in critically ill patients with acute kidney injury.

Authors:  Wenkai Xia; Danyang Zhao; Chenyu Li; Lingyu Xu; Xiajuan Yao; Hong Hu
Journal:  Clin Exp Nephrol       Date:  2022-05-17       Impact factor: 2.617

Review 7.  Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled.

Authors:  Usama Elewa; Maria Dolores Sanchez-Niño; Catalina Martin-Cleary; Beatriz Fernandez-Fernandez; Jesus Egido; Alberto Ortiz
Journal:  Int Urol Nephrol       Date:  2012-09-11       Impact factor: 2.370

8.  Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.

Authors:  Jonathan J Taliercio; Jesse D Schold; James F Simon; Susana Arrigain; Anne Tang; Georges Saab; Joseph V Nally; Sankar D Navaneethan
Journal:  Am J Kidney Dis       Date:  2013-06-12       Impact factor: 8.860

9.  Serum Alkaline Phosphatase Levels and Increased Risk of Brain Hemorrhage in Hemodialysis Patients: The Q-Cohort Study.

Authors:  Hiromasa Kitamura; Shunsuke Yamada; Hiroto Hiyamuta; Ryusuke Yotsueda; Masatomo Taniguchi; Masanori Tokumoto; Kazuhiko Tsuruya; Toshiaki Nakano; Takanari Kitazono
Journal:  J Atheroscler Thromb       Date:  2021-06-10       Impact factor: 4.394

10.  Serum alkaline phosphatase predicts survival outcomes in patients with skeletal metastatic nasopharyngeal carcinoma.

Authors:  Ying Jin; Mei-Qin Yuan; Jun-Qing Chen; Yi-Ping Zhang
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.